论文部分内容阅读
目的探索输卵管妊娠期待疗法可行性。方法选择输卵管妊娠患者255例,分为期待疗法组、MTX药物组、腹腔镜手术组各85例,比较各组治疗成功率及治疗后输卵管通畅率、宫内妊娠率、重复输卵管妊娠率。结果各组治疗成功率比较:期待疗法组与MTX药物治疗组无显著差异(P>0.05);与腹腔镜手术治疗组比较,期待疗法组成功率低于手术组(P<0.05),差异有统计学意义。在治疗成功的病例中,期待组输卵管通畅率优于药物组及手术组,差异有统计学意义(P<0.05),各组宫内妊娠率及重复输卵管妊娠比较无显著差异(P>0.05)。结论输卵管妊娠期待疗法疗效可靠,治疗后输卵管功能恢复良好。
Objective To explore the feasibility of tubal pregnancy expectant therapy. Methods 255 cases of tubal pregnancy were selected and divided into expectant therapy group, MTX drug group and laparoscopic surgery group, 85 cases each. The success rate of treatment and the rate of tubal patency, intrauterine pregnancy and repeated tubal pregnancy were compared. Results The success rate of treatment in each group was compared with that of MTX drug treatment group (P> 0.05). Compared with laparoscopic surgery group, the expected success rate of treatment group was lower than that of operation group (P <0.05) Significance of learning. In the successful treatment of cases, expectant group tubal patency rate is superior to the drug group and surgical group, the difference was statistically significant (P <0.05), the intrauterine pregnancy rate and repeated tubal pregnancy showed no significant difference (P> 0.05) . Conclusions expectant treatment of tubal pregnancy is reliable and the tubal function recovered well after treatment.